Physician profile

Sharon Evette Lister

General Practice (Dentist) · Tucson, AZ

NPI 1760571301

$6,465.33

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Gift$183.49
Food and Beverage$133.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Patterson Companies, INC. $3,102.50 2021-2022
Sirona Dental, INC. $1,500.00 2019
Dentsply Sirona INC $840.79 2019-2021
Ultradent Products INC $762.53 2021-2023 Opalescence
Purelife, LLC $100.00 2019
Envista Holdings Corporation $93.97 2024 Absorbent Points, Eou Cartridges
Align Technology, INC. $38.24 2020-2023 Itero Element 5d, Invisalign
3m Company $27.30 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sharon Evette Lister

$6,465.33

in general payments reported 2019-2025

Years
2019-2024
Top company
Patterson Companies, INC.

https://glasscript.com/doctor/983296/sharon-evette-lister

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.